Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how?
作者信息
Zochios V, Brodie D, Charlesworth M, Parhar K K
机构信息
Department of Cardiothoracic Critical Care and ECMO, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK.
University of Birmingham, Institute of Inflammation and Ageing, Birmingham, UK.
出版信息
Anaesthesia. 2020 Aug;75(8):997-1001. doi: 10.1111/anae.15099. Epub 2020 May 2.
Abstract
摘要
相似文献
1
Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how?为新型冠状病毒肺炎患者提供体外膜肺氧合治疗：是什么、谁来做、何时做以及如何做？
Anaesthesia. 2020 Aug;75(8):997-1001. doi: 10.1111/anae.15099. Epub 2020 May 2.
2
Implementation of veno-venous extracorporeal membrane oxygenation in a COVID-19 convalescent.在一名新冠康复者中实施静脉-静脉体外膜肺氧合。
Anaesthesiol Intensive Ther. 2020;52(3):253-255. doi: 10.5114/ait.2020.97956.
3
Veno-Arterial-Venous Extracorporeal Membrane Oxygenation in a Critically Ill Patient with Coronavirus Disease 2019.COVID-19 危重症患者的静脉-动脉-静脉体外膜肺氧合。
Medicina (Kaunas). 2020 Sep 30;56(10):510. doi: 10.3390/medicina56100510.
4
Extracorporeal membrane oxygenation for respiratory failure in COVID-19 patients: outcome and time-course of clinical and biological parameters.COVID-19患者呼吸衰竭的体外膜肺氧合：临床和生物学参数的结果及时间进程
Can J Anaesth. 2020 Oct;67(10):1486-1488. doi: 10.1007/s12630-020-01727-z. Epub 2020 Jun 1.
5
Severe respiratory failure in the course of coronavirus disease 2019 treated with extracorporeal membrane oxygenation.2019冠状病毒病病程中采用体外膜肺氧合治疗的严重呼吸衰竭
Kardiol Pol. 2020 Sep 25;78(9):913-915. doi: 10.33963/KP.15444. Epub 2020 Jun 20.
6
Extracorporeal Membrane Oxygenation - Crucial Considerations during the Coronavirus Crisis.体外膜肺氧合——新冠疫情期间的关键考量因素
J Cardiothorac Vasc Anesth. 2020 Jul;34(7):1720-1722. doi: 10.1053/j.jvca.2020.03.060. Epub 2020 Apr 7.
7
[COVID-19 respiratory failure: ECMO support for children and young adult patients].[新冠病毒肺炎呼吸衰竭：儿童及青年成人患者的体外膜肺氧合支持]
An Pediatr (Engl Ed). 2020 Sep;93(3):202-205. doi: 10.1016/j.anpedi.2020.05.007. Epub 2020 Jun 11.
8
Extracorporeal membrane oxygenation in the treatment of respiratory failure during COVID‑19.体外膜肺氧合在新型冠状病毒肺炎（COVID-19）呼吸衰竭治疗中的应用
Herz. 2020 Jun;45(4):332-333. doi: 10.1007/s00059-020-04927-x.
9
Extracorporeal membrane oxygenation in COVID-19.COVID-19中的体外膜肺氧合
Cardiol J. 2020;27(2):216-217. doi: 10.5603/CJ.a2020.0053. Epub 2020 Apr 14.
10
Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation.需要体外膜肺氧合的COVID-19患者的血栓形成与凝血障碍
ASAIO J. 2020 Aug;66(8):844-846. doi: 10.1097/MAT.0000000000001208.
引用本文的文献
1
Utilisation and outcomes of a mobile (ambulance and air transport) venovenous extracorporeal membrane oxygenation (VV-ECMO) program in Poland during the COVID-19 pandemic - a retrospective, two-centres, case-series study.在 COVID-19 大流行期间，波兰移动（救护车和空中运输）静脉-静脉体外膜肺氧合（VV-ECMO）项目的使用情况和结果 - 一项回顾性、双中心、病例系列研究。
Anaesthesiol Intensive Ther. 2024;56(2):141-145. doi: 10.5114/ait.2024.139526.
2
Multi-horizon predictive models for guiding extracorporeal resource allocation in critically ill COVID-19 patients.多时间尺度预测模型指导 COVID-19 危重症患者体外资源配置。
J Am Med Inform Assoc. 2023 Mar 16;30(4):656-667. doi: 10.1093/jamia/ocac256.
3
Extracorporeal membrane oxygenation support for SARS-CoV-2: a multi-centered, prospective, observational study in critically ill 92 patients in Saudi Arabia.体外膜肺氧合支持治疗严重急性呼吸综合征冠状病毒 2 型感染：沙特阿拉伯 92 例危重症患者的多中心、前瞻性、观察性研究。
Eur J Med Res. 2021 Dec 9;26(1):141. doi: 10.1186/s40001-021-00618-3.
4
Predictive Value of Eosinophil Count on COVID-19 Disease Progression and Outcomes, a Retrospective Study of Leishenshan Hospital in Wuhan, China.嗜酸粒细胞计数对 COVID-19 疾病进展和结局的预测价值：对中国武汉雷神山医院的回顾性研究。
J Intensive Care Med. 2022 Mar;37(3):359-365. doi: 10.1177/08850666211037326. Epub 2021 Sep 22.
5
COVID-19 and extracorporeal membrane oxygenation: experiences as a patient, general practitioner, wife and mother.新型冠状病毒肺炎与体外膜肺氧合：作为患者、全科医生、妻子和母亲的经历
Anaesth Rep. 2021 May 18;9(1):101-105. doi: 10.1002/anr3.12120. eCollection 2021 Jan-Jun.
6
Mortality Risk Assessment in COVID-19 Venovenous Extracorporeal Membrane Oxygenation.COVID-19 患者行静脉-静脉体外膜肺氧合的死亡率评估。
Ann Thorac Surg. 2021 Dec;112(6):1983-1989. doi: 10.1016/j.athoracsur.2020.12.050. Epub 2021 Jan 21.
7
Emergency biventricular assist device implantation in a patient with suspected COVID-19 disease.为一名疑似新型冠状病毒肺炎患者紧急植入双心室辅助装置
Anaesth Rep. 2020 Dec 8;8(2):196-199. doi: 10.1002/anr3.12079. eCollection 2020 Jul-Dec.
8
Use of Venovenous Extracorporeal Membrane Oxygenation in Critically-Ill Patients With COVID-19.静脉-静脉体外膜肺氧合在新冠肺炎重症患者中的应用
Front Med (Lausanne). 2020 Dec 10;7:614569. doi: 10.3389/fmed.2020.614569. eCollection 2020.
9
Role of extracorporeal membrane oxygenation in critically Ill COVID-19 patients and predictors of mortality.体外膜肺氧合在危重症 COVID-19 患者中的作用和死亡率的预测因素。
Artif Organs. 2021 Jun;45(6):E158-E170. doi: 10.1111/aor.13873. Epub 2020 Dec 28.
10
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.全球慢性阻塞性肺疾病诊断、管理和预防倡议。2020 年 GOLD 科学委员会关于 COVID-19 和慢性阻塞性肺疾病的报告。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36. doi: 10.1164/rccm.202009-3533SO.
本文引用的文献
1
Mobile extracorporeal membrane oxygenation service for severe acute respiratory failure - A review of five years of experience.用于严重急性呼吸衰竭的移动体外膜肺氧合服务——五年经验回顾
J Intensive Care Soc. 2020 May;21(2):134-139. doi: 10.1177/1751143719855207. Epub 2019 Jun 10.
2
Optimizing provision of extracorporeal life support during the COVID-19 pandemic: practical considerations for Canadian jurisdictions.在2019冠状病毒病大流行期间优化体外生命支持的提供：加拿大各司法管辖区的实际考量
CMAJ. 2020 Apr 6;192(14):E372-E374. doi: 10.1503/cmaj.200448. Epub 2020 Mar 26.
3
COVID-19 pneumonia: ARDS or not?新冠肺炎：是否为急性呼吸窘迫综合征？
Crit Care. 2020 Apr 16;24(1):154. doi: 10.1186/s13054-020-02880-z.
4
Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure.最初的体外生命支持组织（ELSO）指导文件：用于患有严重心肺衰竭的COVID-19患者的体外膜肺氧合（ECMO）
ASAIO J. 2020 May;66(5):472-474. doi: 10.1097/MAT.0000000000001173.
5
The Variety of Cardiovascular Presentations of COVID-19.新型冠状病毒肺炎的心血管表现多样性
Circulation. 2020 Jun 9;141(23):1930-1936. doi: 10.1161/CIRCULATIONAHA.120.047164. Epub 2020 Apr 3.
6
The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice.意大利 2019 年冠状病毒病疫情：来自临床实践的建议。
Anaesthesia. 2020 Jun;75(6):724-732. doi: 10.1111/anae.15049. Epub 2020 Mar 30.
7
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).新冠肺炎（COVID-19）患者的心脏受累。
JAMA Cardiol. 2020 Jul 1;5(7):819-824. doi: 10.1001/jamacardio.2020.1096.
8
Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases.COVID-19 大流行期间和其他新发传染病疫情中严重急性呼吸窘迫综合征的体外膜肺氧合服务规划和供应。
Lancet Respir Med. 2020 May;8(5):518-526. doi: 10.1016/S2213-2600(20)30121-1. Epub 2020 Mar 20.
9
Treatment for severe acute respiratory distress syndrome from COVID-19.新型冠状病毒肺炎所致严重急性呼吸窘迫综合征的治疗
Lancet Respir Med. 2020 May;8(5):433-434. doi: 10.1016/S2213-2600(20)30127-2. Epub 2020 Mar 20.
10
Lung Recruitability in COVID-19-associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study.新型冠状病毒肺炎相关急性呼吸窘迫综合征中肺可复张性的单中心观察性研究
Am J Respir Crit Care Med. 2020 May 15;201(10):1294-1297. doi: 10.1164/rccm.202003-0527LE.
Zotero 插件